New light approach eases treatment for kids with birthmarks
NCT ID NCT07353385
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two different ways to use light therapy (photodynamic therapy) for treating port-wine stains—a type of birthmark—in 33 children aged 3 to 12. One group got a lower-power light for a longer time, and the other got a higher-power light for a shorter time. Both methods worked equally well at fading the stains, but the lower-power setting caused less pain during treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
33 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: ·Clinical diagnosis of port-wine stain (PWS). Exclusion Criteria: * concurrent syndromes such as Sturge-Weber or Klippel-Trenaunay syndrome; * a history of previous radiotherapy, photodynamic therapy, or any other intervention in the treatment area that might confound efficacy evaluation; * a known diagnosis of cutaneous photosensitivity, porphyria, or hypersensitivity to porphyrin-based drugs; * administration of photosensitizing medications, including but not limited to griseofulvin, retinoids, thiazide diuretics, sulfonamides, and tetracyclines, within 4 weeks prior to the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Port wine stains are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, 710004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.